<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>Commenti per Diabete: addio piani terapeutici per le glifozine, ecco cosa cambia - Pharma Bullet — Pharma Bullet</title>
    <atom:link href="https://www.pharma-bullet.it/healthcare-policy-ethics/diabete-addio-piani-terapeutici-per-le-glifozine-ecco-cosa-cambia/feed/" rel="self" type="application/rss+xml"/>
    <link>https://www.pharma-bullet.it/healthcare-policy-ethics/diabete-addio-piani-terapeutici-per-le-glifozine-ecco-cosa-cambia/</link>
    <description>Feed RSS dei commenti per «Diabete: addio piani terapeutici per le glifozine, ecco cosa cambia - Pharma Bullet»</description>
    <language>it-IT</language>
    <pubDate>Sun, 03 May 2026 14:03:35 +0000</pubDate>
  </channel>
</rss>
